Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 with no substantive changes to study content, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:55:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A top-level Locations section was added listing California, Massachusetts, New York, North Carolina, Texas, and Utah. The previous per-state location subsections (California Locations, Massachusetts Locations, New York Locations, North Carolina Locations, Texas Locations, Utah Locations) were removed.
    Difference
    0.7%
    Check dated 2025-12-23T21:28:16.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Publications now indicate that PubMed entries are automatically filled in from PubMed and may not relate to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:20:29.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:11:08.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    No additions or deletions are visible on the Study Details page. The content continues to present the Pembrolizumab +/- Bevacizumab for Recurrent GBM study details.
    Difference
    0.3%
    Check dated 2025-11-03T21:03:57.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:33:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.